Literature DB >> 35732823

Fetal endothelial colony-forming cell impairment after maternal kidney transplantation.

Nadia Meyer1, Thu Huong Vu1,2, Lars Brodowski1,2, Bianca Schröder-Heurich1, Constantin von Kaisenberg2, Frauke von Versen-Höynck3,4.   

Abstract

BACKGROUND: Successful pregnancies are nowadays possible after kidney transplantation but are associated with a higher incidence of maternal and fetal complications. Immunosuppressive therapy causes cardiovascular side effects but must be maintained during pregnancy. Little is known about the consequences of maternal kidney transplantation on offspring's endothelial health. Endothelial colony forming cells (ECFCs) represent a highly proliferative subtype of endothelial progenitor cells and are crucial for vascular homeostasis, repair and neovascularization. Therefore, we investigated whether maternal kidney transplantation affects fetal ECFCs' characteristics.
METHODS: ECFCs were isolated from umbilical cord blood of uncomplicated and post-kidney-transplant pregnancies and analyzed for their functional abilities with proliferation, cell migration, centrosome orientation and angiogenesis assays. Further, ECFCs from uncomplicated pregnancies were exposed to either umbilical cord serum from uncomplicated or post-kidney-transplant pregnancies.
RESULTS: Post-kidney-transplant ECFCs showed significantly less proliferation, less migration and less angiogenesis compared to control ECFCs. The presence of post-kidney-transplant umbilical cord serum led to similar functional aberrations of ECFCs from uncomplicated pregnancies.
CONCLUSIONS: These pilot data demonstrate differences in ECFCs' biological characteristics in offspring of women after kidney transplantation. Further studies are needed to monitor offspring's long-term cardiovascular development and to assess possible causal relationships with immunosuppressants, uremia and maternal cardiovascular alterations. IMPACT: Pregnancy after kidney transplantation has become more common in the past years but is associated with higher complications for mother and offspring. Little is known of the impact of maternal kidney transplantation and the mandatory immunosuppressive therapy on offspring vascular development. In this study we are the first to address and detect an impairment of endothelial progenitor cell function in offspring of kidney-transplanted mothers. Serum from post-transplant pregnancies also causes negative effects on ECFCs' function. Clinical studies should focus on long-term monitoring of offspring's cardiovascular health.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 35732823     DOI: 10.1038/s41390-022-02165-x

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  37 in total

Review 1.  In utero programming of cardiovascular disease.

Authors:  D J Barker
Journal:  Theriogenology       Date:  2000-01-15       Impact factor: 2.740

2.  Pulmonary and systemic vascular dysfunction in young offspring of mothers with preeclampsia.

Authors:  Pierre-Yves Jayet; Stefano F Rimoldi; Thomas Stuber; Carlos Salinas Salmòn; Damian Hutter; Emrush Rexhaj; Sébastien Thalmann; Marcos Schwab; Pierre Turini; Céline Sartori-Cucchia; Pascal Nicod; Mercedes Villena; Yves Allemann; Urs Scherrer; Claudio Sartori
Journal:  Circulation       Date:  2010-07-19       Impact factor: 29.690

3.  Cyclosporine and its metabolites in mother and baby.

Authors:  R Venkataramanan; B Koneru; C C Wang; G J Burckart; S N Caritis; T E Starzl
Journal:  Transplantation       Date:  1988-09       Impact factor: 4.939

4.  Prenatal exposure to preeclampsia as an independent risk factor for long-term cardiovascular morbidity of the offspring.

Authors:  Kira Nahum Sacks; Michael Friger; Ilana Shoham-Vardi; Efrat Spiegel; Ruslan Sergienko; Daniella Landau; Eyal Sheiner
Journal:  Pregnancy Hypertens       Date:  2018-06-18       Impact factor: 2.899

Review 5.  Effect of in utero and early-life conditions on adult health and disease.

Authors:  Peter D Gluckman; Mark A Hanson; Cyrus Cooper; Kent L Thornburg
Journal:  N Engl J Med       Date:  2008-07-03       Impact factor: 91.245

Review 6.  Fetal programming of coronary heart disease.

Authors:  David J P Barker
Journal:  Trends Endocrinol Metab       Date:  2002-11       Impact factor: 12.015

7.  Dialysis, transplantation, and pregnancy.

Authors:  J M Davison
Journal:  Am J Kidney Dis       Date:  1991-02       Impact factor: 8.860

Review 8.  Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review.

Authors:  Esther Frances Davis; Merzaka Lazdam; Adam James Lewandowski; Stephanie Anne Worton; Brenda Kelly; Yvonne Kenworthy; Satish Adwani; Andrew R Wilkinson; Kenny McCormick; Ian Sargent; Christopher Redman; Paul Leeson
Journal:  Pediatrics       Date:  2012-05-21       Impact factor: 7.124

Review 9.  Maternal and fetal origins of coronary heart disease.

Authors:  D J Barker
Journal:  J R Coll Physicians Lond       Date:  1994 Nov-Dec

Review 10.  Maternal, foetal and child consequences of immunosuppressive drugs during pregnancy in women with organ transplant: a review.

Authors:  Hugoline Boulay; Séverine Mazaud-Guittot; Jeanne Supervielle; Jonathan M Chemouny; Virginie Dardier; Agnes Lacroix; Ludivine Dion; Cécile Vigneau
Journal:  Clin Kidney J       Date:  2021-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.